Skip to content

A Clinical Study on Acupuncture Treatment for Obese Adolescent Polycystic Ovary Syndrome Based on the Theory of "Dampness as the Primary Cause of Various Diseases"

A Clinical Study on Acupuncture Treatment for Obese Adolescent Polycystic Ovary Syndrome Based on the Theory of "Dampness as the Primary Cause of Various Diseases"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001269
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome (PCOS)

Interventions

"Tonifying Kidney and Resolving Dampness" Acupuncture Group:Based on lifestyle intervention, combined with acupuncture treatment using the "kidney-tonifying and dampness-dispelling" method.
Sham Acupuncture Group:Based on lifestyle intervention, combined with sham acupuncture treatment.

Sponsors

Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
13 Years to 19 Years

Inclusion criteria

Inclusion criteria: 1) Aged between 13 and 19 years old, with no history of sexual activity; 2) Meeting the diagnostic criteria for adolescent polycystic ovary syndrome (PCOS); 3) Meeting the diagnostic criteria for obesity, with a body mass index (BMI) = 25 kg/m²; 4) No history of any Western medical or traditional Chinese medical treatment within the past three months; 5) Voluntarily participating in this trial and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Presence of significant organic lesions or malformations of the reproductive system; 2) Complicated with severe primary diseases such as cardiovascular, liver, kidney, or hematopoietic system disorders, or with mental abnormalities; 3) Use of hormonal medications or drugs affecting glucose metabolism within the three months prior to treatment; 4) Patients concurrently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
BMI;

Secondary

MeasureTime frame
modified Ferriman-Gallwey (mFG) scoring system;FSH;LH;T;WHR;E2;P;PRL;FAI;SHBG;Serum ß-Endorphin;HOMA-IR;TG;HDL;LDL;self-rating anxiety scale,SAS;self-rating depression scale,SDS;polycystic ovary syndrome questionnaire, PCOSQ;

Countries

China

Contacts

Public ContactLingyun Zhang

Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine

763266920@qq.com+86 138 1239 2040

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026